This pathway and its constituents are increased in the bladder cancer tissues of patients, particularly VEGFR-2, and are also related to poor prognosis and recurrence [45], and, as such, the inhibition of this receptor can explain the cytotoxicity of RPV in bladder cancer cells observed in this study. Here, KDR is linked to urinary bladder cancer.